Skip to main content
GoodMoatv1.3
Sign in
NBIX logo

NBIX

CompareEarnings: May 31, 2026

Neurocrine Biosciences Inc

Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic

Biosciences, Inc. Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, endocrine, psychiatric and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science.

Did you know?

Earnings per share grew at a 50.0% CAGR.

Current Price

$131.78

+0.08%

GoodMoat Value

$213.39

61.9% undervalued
Profile
Valuation (TTM)
Market Cap$13.14B
P/E27.45
EV—
P/B4.04
Shares Out99.71M
P/Sales4.59
Revenue$2.86B
EV/EBITDA15.84

Neurocrine Biosciences Inc (NBIX) Company Profile

NBIX Company Information

Biosciences, Inc. Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs.

We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, endocrine, psychiatric and immunological disorders.

The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas.

For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions.

We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

California, USA

NBIX Key Officers

Key officers data coming soon

NBIX Company Profile

Neurocrine Biosciences Inc (NBIX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. It trades on NASDAQ. The company is based in California, USA.

Biosciences, Inc. Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, endocrine, psychiatric and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science.

Market cap is $13.14B. There are 99.7M shares outstanding.

See the full Neurocrine Biosciences Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if NBIX is a good investment.